T-DM1 Boosts Survival in HER2-Positive Breast Cancer ...Middle East

Medscape - News
T-DM1 Boosts Survival in HER2-Positive Breast Cancer
Patients with HER-2 positive early breast cancer with residual invasive disease after neoadjuvant therapy were randomly assigned to receive either T-DM1 or trastuzumab for 14 cycles. Medscape Medical News

Hence then, the article about t dm1 boosts survival in her2 positive breast cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( T-DM1 Boosts Survival in HER2-Positive Breast Cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News